UFP Technologies, Inc. (NASDAQ:UFPT) Shares Sold by Uniplan Investment Counsel Inc.

Uniplan Investment Counsel Inc. lessened its stake in UFP Technologies, Inc. (NASDAQ:UFPT - Free Report) by 12.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,117 shares of the industrial products company's stock after selling 3,324 shares during the period. Uniplan Investment Counsel Inc. owned 0.30% of UFP Technologies worth $5,652,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. AlphaQuest LLC purchased a new position in UFP Technologies during the fourth quarter worth about $25,000. Venturi Wealth Management LLC purchased a new position in UFP Technologies during the fourth quarter worth about $74,000. EverSource Wealth Advisors LLC raised its holdings in UFP Technologies by 24.7% during the fourth quarter. EverSource Wealth Advisors LLC now owns 333 shares of the industrial products company's stock worth $81,000 after purchasing an additional 66 shares in the last quarter. KBC Group NV raised its holdings in UFP Technologies by 37.9% during the fourth quarter. KBC Group NV now owns 375 shares of the industrial products company's stock worth $92,000 after purchasing an additional 103 shares in the last quarter. Finally, Principal Securities Inc. raised its holdings in UFP Technologies by 110.4% during the fourth quarter. Principal Securities Inc. now owns 444 shares of the industrial products company's stock worth $109,000 after purchasing an additional 233 shares in the last quarter. Institutional investors and hedge funds own 87.28% of the company's stock.

Analyst Ratings Changes

Several research analysts recently issued reports on UFPT shares. Raymond James initiated coverage on shares of UFP Technologies in a report on Friday, March 28th. They set a "market perform" rating for the company. StockNews.com cut shares of UFP Technologies from a "hold" rating to a "sell" rating in a report on Thursday, January 23rd.

Insider Activity

In other news, Director Daniel C. Croteau sold 6,846 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $228.41, for a total value of $1,563,694.86. Following the sale, the director now directly owns 1,785 shares in the company, valued at $407,711.85. This represents a 79.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 6.17% of the company's stock.

UFP Technologies Price Performance

UFP Technologies stock traded down $0.09 during mid-day trading on Friday, reaching $206.80. The company had a trading volume of 124,881 shares, compared to its average volume of 79,967. UFP Technologies, Inc. has a 1 year low of $178.26 and a 1 year high of $366.41. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.57 and a quick ratio of 1.43. The company has a market capitalization of $1.59 billion, a P/E ratio of 29.50 and a beta of 1.08. The stock's 50-day simple moving average is $213.99 and its 200-day simple moving average is $256.42.

UFP Technologies (NASDAQ:UFPT - Get Free Report) last issued its earnings results on Tuesday, February 25th. The industrial products company reported $2.46 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.01 by $0.45. UFP Technologies had a net margin of 11.74% and a return on equity of 18.92%. The company had revenue of $144.07 million during the quarter, compared to analysts' expectations of $141.67 million.

UFP Technologies Company Profile

UFP Technologies, Inc designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners.